Working out of Copenhagen, with affiliates in San Francisco and Boston, Novo Holdings is a world-wide life science investor/ venture capital firm.
Novo Holding's mission is to be a supportive owner of the Novo Group companies and to make a growing impact on health, science, and society by generating long-term returns on the assets of the Novo Nordisk Foundation.
Novo Holdings employs investment and business professionals focused on delivering attractive returns for the benefit of the Novo Nordisk Foundation.
Timeline
June 15, 2021
Novo Holdings announces that it has acquired BBI Group ("BBI") from Exponent for an enterprise value of over GBP 400 million.
Invested in
Funding Rounds Participated In
Patents
Further Resources
Title
Author
Link
Type
Date
News
Title
Author
Date
Publisher
Description
FinSMEs
July 27, 2021
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
Brandon May
July 9, 2021
BioSpace
The company launches with the new funding to advance its focus on first-in-class small molecule therapies for neurodegenerative diseases.
FinSMEs
July 9, 2021
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
FinSMEs
June 25, 2021
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
Novo Holdings
June 15, 2021
www.prnewswire.com:443
/PRNewswire/ -- Novo Holdings A/S, a leading global life sciences investor, today announced it has acquired BBI Group ("BBI"), a leading supplier of products...
SHOW MORE
References
Investor
Organization
Venture capital firmVenture Capital Firm attributes
Location
Gentofte Municipality
CopenhagenIndustry
BiotechnologyFounded Date
September 8, 1999
Organization attributes
Parent Organization
Novo Nordisk Foundation
Novo Nordisk
Novozymes
Chr. Hansen
FLSmidth
Veloxis Pharmaceuticals
NNITLegal classification
AktieselskabOther attributes
Wikidata ID
NMD PharmaCountry
Denmark
